Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazyar Mahmoudi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Clinical Pharmacology|October 24, 2018
No alteration of voriconazole concentration by plasmapheresis in a critically ill patientManuela Vay, Kathrin I Foerster, Mazyar Mahmoudi, et al.
Journal of Clinical Pharmacology|November 25, 2020
Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 ActivityMazyar Mahmoudi, Kathrin I Foerster, Jürgen Burhenne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal FailureMazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2018
Reply to Truffot et alMazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, et al.
Clinical Pharmacokinetics|July 17, 2021
Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed CocktailBrit Silja Rohr, Kathrin Isabelle Foerster, Antje Blank, et al.
Current Medical Research and Opinion|April 10, 2021
Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical companyPetra C Moroni-Zentgraf, Christoph Keller, Mazyar Mahmoudi, et al.
Pharmacotherapy|December 27, 2024
The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteersXiaofan Tian, Habib Esmaeili, David Minich, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Pharmacology|October 24, 2018
No alteration of voriconazole concentration by plasmapheresis in a critically ill patientManuela Vay, Kathrin I Foerster, Mazyar Mahmoudi, et al.
Journal of Clinical Pharmacology|November 25, 2020
Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 ActivityMazyar Mahmoudi, Kathrin I Foerster, Jürgen Burhenne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2017
Substantial Impairment of Voriconazole Clearance by High-Dose Meropenem in a Patient With Renal FailureMazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2018
Reply to Truffot et alMazyar Mahmoudi, Thorsten Brenner, Gencay Hatiboglu, et al.
Clinical Pharmacokinetics|July 17, 2021
Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed CocktailBrit Silja Rohr, Kathrin Isabelle Foerster, Antje Blank, et al.
Current Medical Research and Opinion|April 10, 2021
Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical companyPetra C Moroni-Zentgraf, Christoph Keller, Mazyar Mahmoudi, et al.
Pharmacotherapy|December 27, 2024
The effect of carbamazepine, a strong CYP3A inducer, on the pharmacokinetics of zongertinib in healthy male volunteersXiaofan Tian, Habib Esmaeili, David Minich, et al.
Pageof 1